Affinity Construct Purification of Non-Antibody Proteins
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The biotechnology industry faces challenges in rapidly isolating non-antibody proteins from impure mixtures due to the lack of commercially available affinity resins, leading to the need for multi-step purifications that increase resource requirements and limit the study of critical quality attributes in process development and monitoring.
Innovation Solution
A method for purifying non-antibody proteins using a single-step affinity technique involving an affinity construct with a solid support coupled to an affinity ligand that binds the protein, allowing for predictive modeling of product quality attributes and reducing the need for multi-step purifications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If multi-step purifications are used to isolate non-antibody proteins, then product purity is improved, but resource requirements and process complexity increase significantly
Solution Approach 1:
The invention segments the purification process by introducing a specific affinity chromatography step that targets non-antibody proteins selectively. This divides the complex multi-step purification into distinct functional modules: affinity capture step followed by polishing steps, where the affinity step performs the heavy lifting of selective isolation, reducing the burden on subsequent steps.
Solution Approach 2:
The invention uses affinity ligands (such as antibodies, aptamers, or ligands) as intermediaries that specifically bind to non-antibody proteins. These ligands act as mediators between the target protein and the chromatography matrix, enabling selective capture and isolation of non-antibody proteins from complex mixtures without requiring multiple sequential purification steps.
2Manufacturing precision
If multi-step purifications are implemented, then product purity is improved, but processing time and throughput are reduced
Solution Approach 1:
The invention performs preliminary selective capture of non-antibody proteins using affinity chromatography at the beginning of the purification process. By capturing the target protein selectively in the first step based on specific binding interactions, the method eliminates the need for multiple sequential steps to achieve purification, thereby reducing total processing time while maintaining high throughput.
3Productivity
If affinity resins are developed for non-antibody proteins, then single-step purification capability is improved, but development cost and complexity increase
Solution Approach 1:
The invention employs universal affinity ligand platforms (such as antibody-based ligands, aptamers, or small molecule ligands) that can be adapted to target different non-antibody proteins. These universal ligand systems can be coupled to standard chromatography matrices, providing a platform approach that reduces development complexity compared to creating custom resins for each target protein.
Solution Approach 2:
The invention optimizes affinity resin parameters such as ligand density, crosslinking degree, and matrix pore size to balance binding capacity and mass transfer kinetics. By systematically adjusting these parameters, the invention achieves high purification efficiency in single-step processes while controlling development complexity through parameter optimization rather than fundamental redesign.
4Measurement precision
If rapid product isolation is achieved, then measurement accuracy of critical quality attributes is improved, but resource requirements increase
Solution Approach 1:
The invention creates a simplified model system using affinity-purified non-antibody proteins that replicates the critical quality attributes of interest. By isolating the target protein rapidly with high purity, the invention enables accurate measurement of CQAs on a smaller scale, reducing the amount of material and resources needed compared to traditional multi-step purification approaches that require larger volumes to achieve the same measurement accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces resource requirements, increases throughput, and enables timely product quality-based decision-making, facilitating Process Analytical Technology (PAT) in bioprocess control by providing drug substance-equivalent product quality information without the need for actual drug substance production.
Implementation Method 1
contacting the heterogeneous solution comprising the NAP with an affinity construct comprising a solid support coupled to an affinity ligand that binds the NAP
Data Source
AI summary
The invention as disclosed herein provides a method for purifying a non-antibody protein from solution, comprising a chromatography step wherein the solution is passed over an affinity construct containing an affinity ligand-coupled solid support, wherein the affinity construct is associated with a bioprocess unit operation, and isolating the non-antibody protein from solution.